SEARCH

SEARCH BY CITATION

References

  • Bhaumik, M., Muller, V.J., Rozaklis, T., Johnson, L., Dobrenis, K., Bhattacharyya, R., Wurzelmann, S., Finamore, P., Hopwood, J.J., Walkley, S.U. & Stanley, P. (1999) A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Glycobiology 9, 13891396.
  • Boviatsis, E.J., Kouyialis, A.T., Korfias, S. & Sakas, D.E. (2005) Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 107, 289295.
  • Ceuterick, C., Martin, J.J., Libert, J. & Farriaux, J.P. (1980) Sanfilippo A disease in the fetus – comparison with pre- and postnatal cases. Neuropadiatrie 11, 176185.
  • Crawley, A.C., Gliddon, B.L., Auclair, D., Brodie, S.L., Hirte, C., King, B.M., Fuller, M., Hemsley, K.M. & Hopwood, J.J. (2006) Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Brain Res 1104, 117.
  • Dickson, P., McEntee, M., Vogler, C., Le, S., Levy, B., Peinovich, M., Hanson, S., Passage, M. & Kakkis, E. (2007) Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol Genet Metab 91, 6168.
  • Elleder, M., Sokolová, J. & Hrebícek, M. (1997) Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol 93, 379390.
  • Fuller, M., Rozaklis, T., Ramsay, S.L., Hopwood, J.J. & Meikle, P.J. (2004) Disease-specific markers for the mucopolysaccharidoses. Pediatr Res 56, 733738.
  • Ghodsi, A., Stein, C., Derksen, T., Yang, G., Anderson, R.D. & Davidson, B.L. (1998) Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain. Hum Gene Ther 9, 23312340.
  • Gilmartin, R., Bruce, D., Storrs, B.B., Abbott, R., Krach, L., Ward, J., Bloom, K., Brooks, W.H., Johnson, D.L., Madsen, J.R., McLaughlin, J.F. & Nadell, J. (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 15, 7177.
  • Ginsberg, S.D., Galvin, J.E., Lee, V.M., Rorke, L.B., Dickson, D.W., Wolfe, J.H., Jones, M.Z. & Trojanowski, J.Q. (1999) Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains. J Neuropathol Exp Neurol 58, 815824.
  • Hamano, K., Hayashi, M., Shioda, K., Fukatsu, R. & Mizutani, S. (2008) Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue. Acta Neuropathol 115, 547559.
  • Heldermon, C.D., Hennig, A.K., Ohlemiller, K.K., Ogilvie, J.M., Herzog, E.D., Breidenbach, A., Vogler, C., Wozniak, D.F. & Sands, M.S. (2007) Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B. PLoS ONE 2, e772.
  • Hemsley, K.M. & Hopwood, J.J. (2005) Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA). Behav Brain Res 158, 191199.
  • Hemsley, K.M., King, B. & Hopwood, J.J. (2007) Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice. Mol Genet Metab 90, 313328.
  • Hopwood, J.J. & Morris, C.P. (1990) The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment. Mol Biol Med 7, 381404.
  • Hopwood, J.J., Vellodi, A., Scott, H.S., Morris, C.P., Litjens, T., Clements, P.R., Brooks, D.A., Cooper, A. & Wraith, J.E. (1993) Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype. J Inherit Metab Dis 16, 10241033.
  • Jeyakumar, M., Smith, D.A., Williams, I.M., Borja, M.C., Neville, D.C., Butters, T.D., Dwek, R.A. & Platt, F.M. (2004) NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann Neurol 56, 642649.
  • Kakavanos, R., Turner, C.T., Hopwood, J.J., Kakkis, E.D. & Brooks, D.A. (2003) Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I. Lancet 361, 16081613.
  • Kakkis, E., McEntee, M., Vogler, C., Le, S., Levy, B., Belichenko, P., Mobley, W., Dickson, P., Hanson, S. & Passage, M. (2004) Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol Genet Metab 83, 163174.
  • King, B., Savas, P., Fuller, M., Hopwood, J. & Hemsley, K. (2006) Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA. Mol Genet Metab 87, 107112.
  • Li, H.H., Zhao, H.Z., Neufeld, E.F., Cai, Y. & Gómez-Pinilla, F. (2002) Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J Neurosci Res 69, 3038.
  • Matzner, U., Matthes, F., Weigelt, C., Andersson, C., Eistrup, C., Fogh, J. & Gieselmann, V. (2008) Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease. J Mol Med 86, 433442.
  • McGlynn, R., Dobrenis, K. & Walkley, S.U. (2004) Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 480, 415426.
  • Messier, C., Emond, S. & Ethier, K. (1999) New techniques in stereotaxic surgery and anesthesia in the mouse. Pharmacol Biochem Behav 63, 313318.
  • Myerowitz, R., Lawson, D., Mizukami, H., Mi, Y., Tifft, C.J. & Proia, R.L. (2002) Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 11, 13431350.
  • Neufeld, E.F. & Muenzer, J. (2001) The mucopolysaccharidoses. In Scriver, C.R., Beaudet, A.L., Valle, D., Sly, W.S. (eds), The Metabolic & Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill, New York, pp. 34213452.
  • Ohmi, K., Greenberg, D.S., Rajavel, K.S., Ryazantsev, S., Li, H.H. & Neufeld, E.F. (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A 100, 19021907.
  • Paxinos, G. & Franklin, K.B.J. (2001) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
  • Rudich, Z., Peng, P., Dunn, E. & McCartney, C. (2004) Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients. J Pain Symptom Manage 28, 599602.
  • Ryazantsev, S., Yu, W.H., Zhao, H.Z., Neufeld, E.F. & Ohmi, K. (2007) Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B. Mol Genet Metab 90, 393401.
  • Savas, P.S., Hemsley, K.M. & Hopwood, J.J. (2004) Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA. Mol Genet Metab 82, 273285.
  • Scheinberg, A., O’Flaherty, S., Chaseling, R. & Dexter, M. (2001) Continuous intrathecal baclofen infusion for children with cerebral palsy: a pilot study. J Paediatr Child Health 37, 283288.
  • Scott, H.S., Blanch, L., Guo, X.H., Freeman, C., Orsborn, A., Baker, E., Sutherland, G.R., Morris, C.P. & Hopwood, J.J. (1995) Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome. Nat Genet 11, 465467.
  • Settembre, C., Fraldi, A., Jahreiss, L., Spampanato, C., Venturi, C., Medina, D., De Pablo, R., Tacchetti, C., Rubinsztein, D.C. & Ballabio, A. (2008) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17, 119129.
  • Staba, S.L., Escolar, M.L., Poe, M., Kim, Y., Martin, P.L., Szabolcs, P., Allison-Thacker, J., Wood, S., Wenger, D.A., Rubinstein, P., Hopwood, J.J., Krivit, W. & Kurtzberg, J. (2004) Cord-blood transplants from unrelated donors in patients with Hurler’s syndrome. N Engl J Med 350, 19601969.
  • Stoll, G., Jander, S. & Schroeter, M. (2002) Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol 513, 87113.
  • Streit, W.J. & Kreutzberg, G.W. (1987) Lectin binding by resting and reactive microglia. J Neurocytol 16, 249260.
  • Tamagawa, K., Morimatsu, Y., Fujisawa, K., Hara, A. & Taketomi, T. (1985) Neuropathological study and chemico-pathological correlation in sibling cases of Sanfilippo syndrome type B. Brain Dev 7, 599609.
  • Van Hove, J.L., Wevers, R.A., Van Cleemput, J., Moerman, P., Sciot, R., Matthijs, G., Schollen, E., De Jong, J.G., Carey, W.F., Muller, V., Nicholls, C., Perkins, K. & Hopwood, J.J. (2003) Late-onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndrome. Am J Med Genet A 118, 382387.
  • Villani, G.R., Gargiulo, N., Faraonio, R., Castaldo, S., Gonzalez, Y., Reyero, E. & Di Natale, P. (2007) Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 85, 612622.
  • Wada, R., Tifft, C.J. & Proia, R.L. (2000) Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci U S A 97, 1095410959.
  • Wu, Y.P. & Proia, R.L. (2004) Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci U S A 101, 84258430.
  • Zafeiriou, D.I., Savvopoulou-Augoustidou, P.A., Sewell, A., Papadopoulou, F., Badouraki, M., Vargiami, E., Gombakis, N.P. & Katzos, G.S. (2001) Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo’s syndrome B). Brain Dev 23, 385389.